Since its development in 1985, recombinant human growth hormone (GH) has been widely available for the treatment in childhood of many indications, including growth hormone deficiency (GHD), Turner syndrome, chronic renal insufficiency, and short children born small for gestational age [1]. The gene discussed is GH1; the disease is chronic kidney disease.